Abstract: Provided is a novel bacterial strain Bacteroides vulgatus MGM001 (Bacteroides vulgatus MGM001) and its use. The LPS from the strain of the subject matter has cytotoxicity weaker than the conventional ones and shows synergistic effect on the inhibition of biofilm formation when used in combination with LTA.

Abstract: The present invention relates to a method for detecting a target analyte using a gold nanoparticle, comprising growing a copper crystal specifically on a gold nanoparticle by treating the gold nanoparticle with a solution comprising a copper ion, a polymer having a primary or secondary amine group, and a reducing agent, a composition for amplifying a signal used in the detection method above, and a kit for detecting a target analyte comprising the composition for amplifying a signal above.

Abstract: The present disclosure relates to methods of predicting treatment sensitivity or drug resistance, especially for epidermal growth factor receptor (EGFR) inhibitors using leucine proline-enriched proteoglycan 1 (LEPRE1) gene expression level before or during a treatment, methods of discovering companion diagnostic biomarkers using efficacies of EGFR inhibitors on the expression of genes, including genes involved with regulation of extracellular matrix environment, or metabolism of collagen, and methods of predicting treatment sensitivity or resistance of drugs using the companion diagnostic biomarkers thereof.

Abstract: Provided is a novel bacterial strain Bacteroides vulgatus MGM001 (Bacteroides vulgatus MGM001) and its use. The LPS from the strain of the subject matter has cytotoxicity weaker than the conventional ones and shows synergistic effect on the inhibition of biofilm formation when used in combination with LTA.

Abstract: Disclosed are a DNA aptamer specifically binding to the Her2 (ERBB2) receptor involved in the onset of breast cancer, a composition for the suppression of cancer metastasis comprising the same as an active ingredient, and a composition for the diagnosis of cancer comprising the same as an active ingredient. Due to its binding mechanism being different from that of the conventional antibody, the aptamer can be effectively used for suppressing cancer metastasis and diagnosing cancer.

Abstract: Disclosed are a DNA aptamer specifically binding to the Her2 (ERBB2) receptor involved in the onset of breast cancer, a composition for the suppression of cancer metastasis comprising the same as an active ingredient, and a composition for the diagnosis of cancer comprising the same as an active ingredient. Due to its binding mechanism being different from that of the conventional antibody, the aptamer can be effectively used for suppressing cancer metastasis and diagnosing cancer.

Abstract: Disclosed are a method and a system for estimating food commodity intakes.

Abstract: Disclosed herein is a system for managing chemicals using Radio-Frequency Identification (RFID). A storage facility identification tag, attached to a chemical storage facility in a laboratory, stores the unique identification code of the chemical storage facility and a list of chemicals. A chemical identification tag, attached to the cover of a chemical container, stores the unique identification code of the chemical storage facility and chemical-related information. A mobile terminal, provided with an RFID reader, receives and outputs the unique identification code of the chemical storage facility, the list of the chemicals, and the chemical-related information.

Abstract: Disclosed herein is a method of preparing trans fat-free oils and fats by an enzymatic interesterification (EI), and trans fat-free oils and fats prepared by the method. Specifically, the method comprises the steps of: 1) mixing fully hydrogenated fat derived from vegetable oil with RBD olive oil; 2) adding lipase to the mixed oil and reacting the mixed oil with lipase at 65 to 80° C. for 1 to 4 hours (1st reaction step); and 3) reacting the mixed oil from step 2) with the lipase at 40 to 60° C. for 44 to 47 hours (2nd reaction step).